Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

Presentation TVT 2023

Left Ventricular Remodeling after JenaValve Trilogy Transcatheter Aortic Valve Replacement in Patients with Pure Aortic Regurgitation

Presenter: Lauren Ranard

June 09, 2023

Presentation TVT 2023

Some Newer Kids on the Block: Venus A, JenaValve, Myval, Anteris, and More…

Presenter: Eberhard Grube

June 08, 2023

Presentation TVT 2023

JenaValve

Presenter: Matti Adam

June 08, 2023

Presentation TVT 2022

TAVR with JenaValve system following degenerative aortic valve repair with severe aortic regurgitation.

Presenter: Jubin Joseph

June 09, 2022

Presentation TVT 2022

JenaValve to treat a degenerative regurgitant aortic valve following previous Ross procedure with no annular calcium.

Presenter: Jubin Joseph

June 09, 2022

Presentation TVT 2022

Treating AR with TAVR: challenges, techniques, outcomes and a look at early real-world data with the Jenavalve Trilogy TAVR System

Presenter: Ravi Ramana

June 08, 2022

Presentation TVT 2022

Rapidly Evolving EU Experiences With the JenaValve for AR and AS

Presenter: Matti Adam

June 08, 2022

Presentation TVT 2022

Updates on the Dedicated JenaValve TAVR System and the ALIGN AR Trial

Presenter: Vinod Thourani

June 08, 2022

Presentation TVT 2021

First Transfemoral JenaValve Trilogy Implantation for Severe Aortic Insufficiency in a LVAD Patient

Presenter: Lauren Ranard

July 22, 2021

Presentation TVT 2021

Case Presentation 2: High-Risk Severe AR with JenaValve TAVR

Presenter: Lauren Ranard

July 21, 2021

Presentation TVT 2019

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Presenter: Torsten Vahl

June 15, 2019

Presentation TVT 2019

2 Illustrative Cases – A Case-Based Discussion

Presenter: Raj Makkar

June 13, 2019

Presentation TVT 2019

The Anatomically 'Correct' JenaValve TAVR System – Best for Pure AR and Low Coronaries – EFS Results

Presenter: Torsten Vahl

June 13, 2019

Presentation TVT 2019

Case: JenaValve for Pure Aortic Regurgitation

Presenter: Torsten Vahl

June 13, 2019

Presentation TVT 2019

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Presenter: Torsten Vahl

June 13, 2019

Presentation TVT 2017

The Anatomically Correct JenaValve TAVR System Pure AR Treatment

Presenter: Hendrik Treede

June 16, 2017

Presentation TVT 2016

The JenaValve TAVR System: Status Updates

Presenter: Hendrik Treede

June 16, 2016

Video

TVT 2019: Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

June 15, 2019

Advertisement

Left Ventricular Remodeling after JenaValve Trilogy Transcatheter Aortic Valve Replacement in Patients with Pure Aortic Regurgitation

Some Newer Kids on the Block: Venus A, JenaValve, Myval, Anteris, and More…

JenaValve

TAVR with JenaValve system following degenerative aortic valve repair with severe aortic regurgitation.

JenaValve to treat a degenerative regurgitant aortic valve following previous Ross procedure with no annular calcium.

Treating AR with TAVR: challenges, techniques, outcomes and a look at early real-world data with the Jenavalve Trilogy TAVR System

Rapidly Evolving EU Experiences With the JenaValve for AR and AS

Updates on the Dedicated JenaValve TAVR System and the ALIGN AR Trial

First Transfemoral JenaValve Trilogy Implantation for Severe Aortic Insufficiency in a LVAD Patient

Case Presentation 2: High-Risk Severe AR with JenaValve TAVR

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

2 Illustrative Cases – A Case-Based Discussion

The Anatomically 'Correct' JenaValve TAVR System – Best for Pure AR and Low Coronaries – EFS Results

Case: JenaValve for Pure Aortic Regurgitation

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

The Anatomically Correct JenaValve TAVR System Pure AR Treatment

The JenaValve TAVR System: Status Updates

TVT 2019: Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content